Company: PGEN
Filing Date: 2025-06-30
Form Type: 8-K
Source: 0000950103-25-008124
Chunk: 0

Company: PRECIGEN, INC.
Filing Date: 2025-06-30
Form: 8-K
Item: Item 5.02
Chunk 0
---
Item 5.02.      Departure of Directors or Certain Officers; Election of Directors;               

At the Annual Meeting of Stockholders
of Precigen, Inc. (the “ Company”) held on June 26, 2025 (the “2025 Annual Meeting”), the Company’s stockholders
approved an amendment to the Precigen, Inc. 2023 Omnibus Incentive Plan, as amended (the “2023 Plan”), to increase the number
of shares of common stock available for issuance thereunder by 11.5 million (the “2023 Plan Amendment No. 2”). The approval
of the 2023 Plan Amendment No. 2 had been previously approved by the Company’s Board of Directors (the “ Board”), subject
to stockholder approval.

The 2023 Plan Amendment No. 2 amends the 2023 Plan, which was previously
approved by the Company’s stockholders on June 8, 2023, and subsequently amended by the Company’s stockholders on July 5,
2024. The principal features of the 2023 Plan Amendment No. 2 are described in detail under “ Proposal 6 - Approval of an Amendment
to the Precigen, Inc. 2023 Omnibus Incentive Plan, as Amended (the “2023 Plan”)” of the Company’s Definitive Proxy
Statement on Schedule 14A for the 2025 Annual Meeting filed by the Company with the Securities and Exchange Commission on May 16, 2025
(the “ Proxy Statement”). The full text of the 2023 Plan Amendment No. 2 is attached as Annex A to the Proxy Statement.